News coverage about CME Group (NASDAQ:CME) has trended somewhat positive on Friday, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 45.9673319626092 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news headlines that may have impacted Accern Sentiment’s scoring:
- Equities Analysts Offer Predictions for CME Group’s FY2020 Earnings (CME) (americanbankingnews.com)
- REFILE-CME Group takes heat over large, private grain trades (feeds.reuters.com)
- CME Group (CME) Downgraded by BidaskClub to Hold (americanbankingnews.com)
- CME Group's (CME) Q1 Volumes Mark Highest Quarterly ADV (finance.yahoo.com)
Shares of CME opened at $162.99 on Friday. The firm has a market cap of $54,628.39, a PE ratio of 34.17, a P/E/G ratio of 2.27 and a beta of 0.56. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.03 and a current ratio of 1.03. CME Group has a 1-year low of $114.82 and a 1-year high of $171.71.
The firm also recently declared a quarterly dividend, which was paid on Monday, March 26th. Shareholders of record on Friday, March 9th were issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.72%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s dividend payout ratio is presently 58.70%.
Several analysts have recently weighed in on CME shares. Bank of America lifted their price target on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, February 2nd. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research note on Tuesday, January 2nd. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, March 27th. Sandler O’Neill reissued a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research note on Friday, February 2nd. Finally, Barclays boosted their price objective on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $157.77.
In other CME Group news, Chairman Terrence A. Duffy sold 20,000 shares of the company’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the sale, the chairman now directly owns 99,239 shares of the company’s stock, valued at $15,050,586.74. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO John W. Pietrowicz sold 7,500 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,376 shares in the company, valued at $4,904,964. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,699 shares of company stock worth $6,266,062. 0.57% of the stock is owned by corporate insiders.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.